Berenson Stephen 4
4 · Seres Therapeutics, Inc. · Filed Jul 2, 2025
Insider Transaction Report
Form 4
Berenson Stephen
Director
Transactions
- Award
Stock Option (right to buy)
2025-07-01+11,470→ 11,470 totalExercise: $10.71Exp: 2035-07-01→ Common Stock (11,470 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in four equal quarterly installments occurring on October 1, 2025, January 1, 2026, April 1, 2026, and July 1, 2026, provided that if the issuer's 2026 annual meeting of stockholders occurs before July 1, 2026, the final quarterly vesting installment will vest on the day immediately prior to the date of such annual meeting, in each case, subject to the reporting person continuing in service on the Board as a non-employee director through the applicable vesting date.